Qualigen Therapeutics Inc.
13F holders, Q3 2024 (September 30)19holders −1
3new positions
4sold out
1famous investor
$0.17avg. 13F price*
At the end of Q3 2024, 19 institutions reported holding Qualigen Therapeutics Inc. in their 13F filings, down 1 from Q2 2024. 3 opened new positions and 4 sold out. The largest holders were UBS Group AG ($35K), Citadel Advisors ($26K) and HRT Financial LP ($16K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Qualigen Therapeutics Inc.
- CUSIP
- 74754R202
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $28K |
| Exits | 4 | $19K |
All 13F filers, Q2 2024 → Q3 2024: 351,461 shares bought and 114,159 shares sold, net +237,302 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| UBS Group AG | 0.00% | Add +194.2% | 204,509 | $35K |
| Citadel Advisors | 0.00% | New | 153,607 | $26K |
| HRT Financial LP | 0.00% | Add +58.9% | 97,798 | $16K |
| Geode Capital Management, LLC | 0.00% | Add +51.4% | 45,759 | $8K |
| BlackRock, Inc. | 0.00% | — | 25,607 | $4K |
| Vanguard Group Inc. | 0.00% | No change | 22,827 | $4K |
| XTX Topco Ltd | 0.00% | Reduce -14.1% | 19,872 | $3K |
| Cresset Asset Management, LLC | 0.00% | No change | 16,000 | $3K |
| Northern Trust Corp. | 0.00% | No change | 11,899 | $2K |
| State Street Corp. | 0.00% | No change | 10,930 | $2K |
| Jump Financial, LLC | 0.00% | New | 10,164 | $2K |
| HighMark Wealth Management LLC | 0.00% | No change | 8,009 | $1K |
| Bank of America Corp. | 0.00% | Add +1694.2% | 933 | $159 |
| US Bancorp \de | 0.00% | No change | 824 | $140 |
| Group One Trading LLC | 0.00% | No change | 423 | $72 |
| JPMorgan Chase & Co. | 0.00% | No change | 252 | $43 |
| Signaturefd, LLC | 0.00% | New | 20 | $3 |
| Archer Investment Corp | 0.00% | No change | 16 | $3 |
| Royal Bank of Canada | 0.00% | No change | 4 | $0 |
"% of holder's portfolio" is QUALIGEN THERAPEUTICS INC's weight in each manager's 13F, not the share of Qualigen Therapeutics Inc. the manager owns.